,Set,NGenes,Direction,PValue,FDR
1,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,17,Up,8.38050179150425e-05,0.068887724726165
2,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,72,Up,0.000336603045928643,0.13795975045649
3,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,15,Up,0.000503502738892301,0.13795975045649
4,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,5,Up,0.00086999876761563,0.163225457587353
5,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,28,Up,0.00099285558143159,0.163225457587353
6,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Up,0.00144815186287467,0.19839680521383
7,WP_PTF1A_RELATED_REGULATORY_PATHWAY,6,Up,0.00271085158599004,0.247710548542505
8,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,22,Up,0.00306006030290732,0.247710548542505
9,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Up,0.00306840670697911,0.247710548542505
10,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Up,0.00323978605513932,0.247710548542505
11,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,19,Up,0.00352458941413965,0.247710548542505
12,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,89,Up,0.00376595776528919,0.247710548542505
13,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,5,Up,0.00391756341977198,0.247710548542505
14,WP_CREATINE_PATHWAY,2,Down,0.00626551443634787,0.307667419020834
15,WP_MEVALONATE_PATHWAY,7,Up,0.00628130883995552,0.307667419020834
16,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,16,Up,0.00633508554045042,0.307667419020834
17,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,10,Up,0.00636295148826543,0.307667419020834
18,WP_IRON_METABOLISM_IN_PLACENTA,8,Down,0.0081573384149929,0.363686643705366
19,WP_PROSTAGLANDIN_SIGNALING,19,Up,0.00900439952104145,0.363686643705366
20,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,16,Up,0.00920665235679777,0.363686643705366
21,WP_COMPLEMENT_ACTIVATION,12,Down,0.00929126462021008,0.363686643705366
22,WP_HYPERTROPHY_MODEL,13,Up,0.00979008541061688,0.365793191251231
23,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,40,Up,0.0120386584286649,0.423809402759432
24,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,19,Up,0.0123739971608593,0.423809402759432
25,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,9,Up,0.0151211867097438,0.497184619016375
26,WP_ENDOCHONDRAL_OSSIFICATION,26,Up,0.0167906571330583,0.511182228273109
27,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,26,Up,0.0167906571330583,0.511182228273109
28,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,32,Up,0.0179835627300104,0.527946020145305
29,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,35,Up,0.0217754052427004,0.617220107224129
30,WP_MACROPHAGE_MARKERS,8,Down,0.0226858513978033,0.621592328299812
31,WP_GASTRIN_SIGNALING,92,Up,0.0301608443168591,0.790788497231333
32,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Down,0.0307849536635069,0.790788497231333
33,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,14,Up,0.0329382071888393,0.810242313175934
34,WP_BLOOD_CLOTTING_CASCADE,5,Up,0.03528227498774,0.810242313175934
35,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,23,Up,0.0362750971762418,0.810242313175934
36,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,26,Up,0.0389718845670055,0.810242313175934
37,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Up,0.0403887751334494,0.810242313175934
38,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,51,Down,0.0406101101460638,0.810242313175934
39,WP_TRANSSULFURATION_PATHWAY,8,Down,0.0415586716021462,0.810242313175934
40,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Up,0.0422873817416031,0.810242313175934
41,WP_MONOAMINE_GPCRS,3,Up,0.044181115851965,0.810242313175934
42,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,37,Up,0.0454712696760222,0.810242313175934
43,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,4,Up,0.0462403811595578,0.810242313175934
44,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,37,Up,0.046721453837094,0.810242313175934
45,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,32,Up,0.0479763440042317,0.810242313175934
46,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,10,Up,0.048543625450313,0.810242313175934
47,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,32,Up,0.049413053604402,0.810242313175934
48,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Down,0.0498090994772739,0.810242313175934
49,WP_HEART_DEVELOPMENT,16,Up,0.0507193247220479,0.810242313175934
50,WP_ZINC_HOMEOSTASIS,21,Up,0.0512225326557599,0.810242313175934
51,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,9,Down,0.0512474128797491,0.810242313175934
52,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,6,Down,0.0512562047264581,0.810242313175934
53,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Up,0.0547585416972346,0.842191216772307
54,WP_CCL18_SIGNALING,20,Up,0.0570969048589165,0.842191216772307
55,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Up,0.0593104797237457,0.842191216772307
56,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Up,0.0597734617170829,0.842191216772307
57,WP_SERINE_METABOLISM,5,Down,0.0602512007642564,0.842191216772307
58,WP_G13_SIGNALING,29,Up,0.060301709942787,0.842191216772307
59,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,37,Down,0.0604492479191802,0.842191216772307
60,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Up,0.0650151631566325,0.859399762305231
61,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Up,0.0673582749146011,0.859399762305231
62,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Down,0.0678784710692209,0.859399762305231
63,WP_WNT_SIGNALING_AND_PLURIPOTENCY,59,Up,0.0683807815990917,0.859399762305231
64,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,43,Down,0.0684533340658444,0.859399762305231
65,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,12,Up,0.0702874900399013,0.859399762305231
66,WP_TGFB_SMAD_SIGNALING,7,Up,0.0708944300080116,0.859399762305231
67,WP_GPR40_PATHWAY,7,Down,0.0711645490225039,0.859399762305231
68,WP_SMALL_LIGAND_GPCRS,7,Up,0.0726556457940529,0.859399762305231
69,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,21,Up,0.0745583389997886,0.859399762305231
70,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,28,Up,0.0747210739677377,0.859399762305231
71,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,4,Up,0.0762423715423211,0.859399762305231
72,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Up,0.0770506640109256,0.859399762305231
73,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,69,Up,0.0775127688996751,0.859399762305231
74,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Up,0.0776032926928536,0.859399762305231
75,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Down,0.081780402288755,0.859399762305231
76,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,12,Down,0.0823787210423068,0.859399762305231
77,WP_ALANINE_AND_ASPARTATE_METABOLISM,5,Up,0.0834560293179279,0.859399762305231
78,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,11,Up,0.0837925127509902,0.859399762305231
79,WP_GLYOXYLATE_METABOLISM,5,Up,0.0858245487464872,0.859399762305231
80,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,35,Up,0.0883917892283195,0.859399762305231
81,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Down,0.0894454771125484,0.859399762305231
82,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Down,0.0900245196045761,0.859399762305231
83,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,128,Up,0.091383400860194,0.859399762305231
84,WP_IL19_SIGNALING,20,Up,0.0930751351743982,0.859399762305231
85,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Up,0.0934038355761394,0.859399762305231
86,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Down,0.0951380563609098,0.859399762305231
87,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Down,0.0951462585000853,0.859399762305231
88,WP_MICROTUBULE_CYTOSKELETON_REGULATION,35,Up,0.0956220130276838,0.859399762305231
89,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,45,Down,0.0956252291647933,0.859399762305231
90,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Up,0.096672439594805,0.859399762305231
91,WP_SPINA_BIFIDA,10,Down,0.0978769001617381,0.859399762305231
92,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,20,Down,0.0979564520313582,0.859399762305231
93,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,8,Up,0.100627062638979,0.859399762305231
94,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,9,Down,0.102910086455194,0.859399762305231
95,WP_INFLAMMATORY_RESPONSE_PATHWAY,13,Down,0.103046489341908,0.859399762305231
96,WP_NRF2_PATHWAY,71,Up,0.103749958726742,0.859399762305231
97,WP_MINERALOCORTICOID_BIOSYNTHESIS,5,Down,0.104564694322429,0.859399762305231
98,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,5,Up,0.10664838465565,0.859399762305231
99,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,18,Up,0.107805660727775,0.859399762305231
100,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Up,0.110943696513142,0.859399762305231
101,WP_COPPER_HOMEOSTASIS,39,Up,0.110945760716192,0.859399762305231
102,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Up,0.11160380996991,0.859399762305231
103,WP_VEGFAVEGFR2_SIGNALING,334,Up,0.11222805201713,0.859399762305231
104,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Up,0.112619611909768,0.859399762305231
105,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,4,Up,0.11740533989656,0.859399762305231
106,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Down,0.1205223823107,0.859399762305231
107,WP_DOPAMINE_METABOLISM,7,Up,0.121605483309825,0.859399762305231
108,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,6,Up,0.122053036341084,0.859399762305231
109,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,14,Up,0.124996743633146,0.859399762305231
110,WP_MALE_INFERTILITY,66,Down,0.126416050543912,0.859399762305231
111,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,11,Up,0.127047265404582,0.859399762305231
112,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Up,0.127073603756314,0.859399762305231
113,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,36,Up,0.127843174391454,0.859399762305231
114,WP_NOTCH_SIGNALING_WP268,35,Up,0.128480035601584,0.859399762305231
115,WP_PROXIMAL_TUBULE_TRANSPORT,25,Up,0.129681280768632,0.859399762305231
116,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,11,Down,0.130541402409649,0.859399762305231
117,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,76,Up,0.1312855512696,0.859399762305231
118,WP_LIVER_X_RECEPTOR_PATHWAY,5,Down,0.13156336263659,0.859399762305231
119,WP_SELENIUM_MICRONUTRIENT_NETWORK,48,Up,0.132702470411759,0.859399762305231
120,WP_FATTY_ACID_TRANSPORTERS,10,Up,0.133201578023797,0.859399762305231
121,WP_HOMOLOGOUS_RECOMBINATION,11,Down,0.133487837201042,0.859399762305231
122,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,8,Down,0.134235711114374,0.859399762305231
123,WP_MEASLES_VIRUS_INFECTION,99,Up,0.135623482041862,0.859399762305231
124,WP_NUCLEAR_RECEPTORS,20,Down,0.138186866463066,0.859399762305231
125,WP_BIOGENIC_AMINE_SYNTHESIS,1,Up,0.138916253251345,0.859399762305231
126,WP_NEUROTRANSMITTER_DISORDERS,1,Up,0.138916253251345,0.859399762305231
127,WP_GLUCOCORTICOID_BIOSYNTHESIS,6,Down,0.140812009418509,0.859399762305231
128,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Up,0.141106172994103,0.859399762305231
129,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,21,Up,0.141456764183008,0.859399762305231
130,WP_OXIDATIVE_STRESS_RESPONSE,21,Up,0.141506871627956,0.859399762305231
131,WP_RETINOL_METABOLISM,6,Up,0.14220818695445,0.859399762305231
132,WP_NONHOMOLOGOUS_END_JOINING,10,Down,0.142675542088166,0.859399762305231
133,WP_10Q22Q23_COPY_NUMBER_VARIATION,27,Up,0.143075946886262,0.859399762305231
134,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,11,Up,0.143828317043226,0.859399762305231
135,WP_ONECARBON_METABOLISM,22,Down,0.14477918394637,0.859399762305231
136,WP_VITAMIN_B12_METABOLISM,22,Down,0.145019417600644,0.859399762305231
137,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,29,Up,0.146030937175298,0.859399762305231
138,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Up,0.147387192165337,0.859399762305231
139,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,7,Up,0.147612908154161,0.859399762305231
140,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,43,Up,0.148314097938693,0.859399762305231
141,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,39,Up,0.148541841643265,0.859399762305231
142,WP_SPHINGOLIPID_PATHWAY,19,Up,0.152112661560054,0.859399762305231
143,WP_THERMOGENESIS,74,Up,0.153049027028479,0.859399762305231
144,WP_CELL_DIFFERENTIATION_INDEX,7,Up,0.153406802394459,0.859399762305231
145,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,7,Up,0.153503854917203,0.859399762305231
146,WP_FOCAL_ADHESION,117,Up,0.153662188782136,0.859399762305231
147,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,4,Up,0.153688278660425,0.859399762305231
148,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,11,Down,0.157739422606992,0.865898838945416
149,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,21,Down,0.158789951838614,0.865898838945416
150,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Up,0.158813434483382,0.865898838945416
151,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,15,Up,0.159064141947394,0.865898838945416
152,WP_TAMOXIFEN_METABOLISM,2,Down,0.160484819214467,0.867885009172974
153,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,63,Down,0.162480830035457,0.872936224112063
154,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Down,0.163645430717987,0.873484052273928
155,WP_PDGFRBETA_PATHWAY,26,Up,0.165138106917231,0.873763138352186
156,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,86,Up,0.165823661293116,0.873763138352186
157,WP_RANKLRANK_SIGNALING,47,Down,0.167960718545109,0.879386692000506
158,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,19,Up,0.172159190921161,0.883707231372809
159,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,10,Up,0.172593196235066,0.883707231372809
160,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Down,0.175240822142,0.883707231372809
161,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,47,Up,0.175957571936617,0.883707231372809
162,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,61,Up,0.176452298560644,0.883707231372809
163,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,15,Up,0.177472753917164,0.883707231372809
164,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,2,Down,0.177705608267644,0.883707231372809
165,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,42,Up,0.17830880904535,0.883707231372809
166,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,52,Up,0.17853336064078,0.883707231372809
167,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Up,0.179549728989295,0.883707231372809
168,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,11,Up,0.181709852849253,0.883707231372809
169,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,22,Up,0.18472628106185,0.883707231372809
170,WP_IL3_SIGNALING,46,Up,0.186202792983933,0.883707231372809
171,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,49,Down,0.187024605556179,0.883707231372809
172,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,25,Down,0.187299721356003,0.883707231372809
173,WP_7OXOC_AND_7BETAHC_PATHWAYS,17,Up,0.188304895398401,0.883707231372809
174,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,7,Down,0.189466615649255,0.883707231372809
175,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,46,Up,0.190173375524784,0.883707231372809
176,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,12,Up,0.190281272223785,0.883707231372809
177,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Up,0.19028732354378,0.883707231372809
178,WP_CHOLESTEROL_METABOLISM,53,Up,0.193815702563001,0.895036559026891
179,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Up,0.197175569708532,0.905465465365438
180,WP_GLYCOLYSIS_IN_SENESCENCE,11,Up,0.202106978735661,0.918477998131108
181,WP_TARGET_OF_RAPAMYCIN_SIGNALING,32,Up,0.202504783424154,0.918477998131108
182,WP_RAC1PAK1P38MMP2_PATHWAY,51,Up,0.20684859232205,0.918477998131108
183,WP_ALLOGRAFT_REJECTION,50,Down,0.206870743658558,0.918477998131108
184,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,14,Up,0.206873081870014,0.918477998131108
185,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,41,Up,0.207452436455944,0.918477998131108
186,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,56,Up,0.20783078789828,0.918477998131108
187,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Down,0.212681360617931,0.929915310786912
188,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Down,0.212681360617931,0.929915310786912
189,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,54,Up,0.216982305297183,0.93082651113838
190,WP_SEROTONIN_AND_ANXIETY,6,Up,0.217560903357798,0.93082651113838
191,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Down,0.21760301724753,0.93082651113838
192,WP_SILDENAFIL_TREATMENT,10,Down,0.218595595061681,0.93082651113838
193,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Up,0.221067685905477,0.93082651113838
194,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,16,Up,0.222338750752359,0.93082651113838
195,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,23,Down,0.226219961921218,0.93082651113838
196,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,10,Up,0.227026838528927,0.93082651113838
197,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Up,0.227533977739344,0.93082651113838
198,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,56,Up,0.229080593643994,0.93082651113838
199,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,14,Up,0.229218618946957,0.93082651113838
200,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,24,Up,0.230541240295307,0.93082651113838
201,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Up,0.230660378338166,0.93082651113838
202,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,17,Down,0.230959672758592,0.93082651113838
203,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,19,Up,0.231478499903566,0.93082651113838
204,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,24,Down,0.231809894359655,0.93082651113838
205,WP_NUCLEAR_RECEPTORS_METAPATHWAY,175,Up,0.233968395841862,0.93082651113838
206,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Up,0.234526418392117,0.93082651113838
207,WP_FOLATE_METABOLISM,35,Down,0.235912275695872,0.93082651113838
208,WP_EPO_RECEPTOR_SIGNALING,23,Down,0.237563518836107,0.93082651113838
209,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,26,Down,0.238647348469527,0.93082651113838
210,WP_CANONICAL_NFKB_PATHWAY,8,Down,0.243638866997693,0.93082651113838
211,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,40,Down,0.245122898718856,0.93082651113838
212,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,13,Up,0.245160520603061,0.93082651113838
213,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,29,Up,0.245655882938136,0.93082651113838
214,WP_ACETYLCHOLINE_SYNTHESIS,4,Down,0.248532482024427,0.93082651113838
215,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,9,Down,0.249619146008766,0.93082651113838
216,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,9,Down,0.249619146008766,0.93082651113838
217,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,7,Down,0.250281425210631,0.93082651113838
218,WP_CANCER_PATHWAYS,302,Up,0.250387659210541,0.93082651113838
219,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,71,Down,0.251057518892524,0.93082651113838
220,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Up,0.252947346320992,0.93082651113838
221,WP_GLUTATHIONE_METABOLISM,10,Up,0.253997073396683,0.93082651113838
222,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,15,Up,0.254051082723973,0.93082651113838
223,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,23,Up,0.258490638559229,0.93082651113838
224,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,54,Up,0.259940836558882,0.93082651113838
225,WP_INTERFERONMEDIATED_SIGNALING,15,Down,0.260483817118682,0.93082651113838
226,WP_ATR_SIGNALING,10,Down,0.260490251391665,0.93082651113838
227,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,69,Up,0.261768160535565,0.93082651113838
228,WP_PDGF_PATHWAY,36,Up,0.262601383737566,0.93082651113838
229,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,8,Down,0.262973262061471,0.93082651113838
230,WP_INTERFERON_TYPE_I_SIGNALING,50,Down,0.263882126668104,0.93082651113838
231,WP_PPARALPHA_PATHWAY,15,Down,0.265640603610463,0.93082651113838
232,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,13,Up,0.266925558807201,0.93082651113838
233,WP_PAFAH1B1_COPY_NUMBER_VARIATION,9,Up,0.267118214329383,0.93082651113838
234,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,20,Up,0.27111336081607,0.93082651113838
235,WP_GASTRIC_CANCER_NETWORK_1,16,Up,0.271692928778901,0.93082651113838
236,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,29,Up,0.272265329246191,0.93082651113838
237,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,4,Up,0.272408854638734,0.93082651113838
238,WP_ESTROGEN_RECEPTOR_PATHWAY,8,Down,0.277270971609076,0.93082651113838
239,WP_GLIOBLASTOMA_SIGNALING,66,Down,0.277781655684285,0.93082651113838
240,WP_PURINERGIC_SIGNALING,14,Up,0.277943867580588,0.93082651113838
241,WP_NEUROINFLAMMATION,10,Up,0.279508217524523,0.93082651113838
242,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,25,Up,0.282071605899324,0.93082651113838
243,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,13,Up,0.282131093919622,0.93082651113838
244,WP_PPAR_SIGNALING,39,Down,0.282732844928592,0.93082651113838
245,WP_AGERAGE_PATHWAY,53,Up,0.28468984634732,0.93082651113838
246,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,6,Up,0.286601963992554,0.93082651113838
247,WP_DNA_DAMAGE_RESPONSE,58,Down,0.286772023500387,0.93082651113838
248,WP_ALPHA_6_BETA_4_SIGNALING,25,Down,0.290556008774185,0.93082651113838
249,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,59,Down,0.291115453265652,0.93082651113838
250,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,17,Up,0.291850759494502,0.93082651113838
251,WP_IRINOTECAN_PATHWAY,5,Down,0.292991864503739,0.93082651113838
252,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,18,Down,0.293309009073467,0.93082651113838
253,WP_PREIMPLANTATION_EMBRYO,21,Up,0.294585143120701,0.93082651113838
254,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Up,0.295016315311151,0.93082651113838
255,WP_TYPE_III_INTERFERON_SIGNALING,7,Down,0.296292026055353,0.93082651113838
256,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Down,0.296944653303624,0.93082651113838
257,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,27,Up,0.29965555662503,0.93082651113838
258,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Down,0.299724174717244,0.93082651113838
259,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,47,Up,0.299788355117867,0.93082651113838
260,WP_NRF2ARE_REGULATION,20,Up,0.300199041466243,0.93082651113838
261,WP_RETINOBLASTOMA_GENE_IN_CANCER,68,Down,0.301151206349681,0.93082651113838
262,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Up,0.309175871948881,0.93082651113838
263,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,14,Up,0.309370961156172,0.93082651113838
264,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,26,Up,0.309431599937564,0.93082651113838
265,WP_UNFOLDED_PROTEIN_RESPONSE,24,Up,0.311888504762726,0.93082651113838
266,WP_DNA_MISMATCH_REPAIR,21,Down,0.312250941297527,0.93082651113838
267,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,19,Up,0.31244810070165,0.93082651113838
268,WP_SMALL_CELL_LUNG_CANCER,68,Down,0.313817783119379,0.93082651113838
269,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,32,Up,0.314976891318374,0.93082651113838
270,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,9,Up,0.31539039917383,0.93082651113838
271,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Up,0.315684534624155,0.93082651113838
272,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Down,0.316002024466505,0.93082651113838
273,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Up,0.317383521589536,0.93082651113838
274,WP_ECTODERM_DIFFERENTIATION,76,Up,0.318953108698782,0.93082651113838
275,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,13,Up,0.319764891744103,0.93082651113838
276,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,12,Down,0.319951088613534,0.93082651113838
277,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,17,Up,0.32032527218395,0.93082651113838
278,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,102,Down,0.320865269329921,0.93082651113838
279,WP_HEPATITIS_B_INFECTION,115,Up,0.321413771782048,0.93082651113838
280,WP_PROLACTIN_SIGNALING,69,Down,0.32183589909969,0.93082651113838
281,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,65,Up,0.322118256209428,0.93082651113838
282,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,19,Down,0.323869313423077,0.93082651113838
283,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,2,Up,0.323938347011646,0.93082651113838
284,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Up,0.32497795789265,0.93082651113838
285,WP_PANCREATIC_CANCER_SUBTYPES,5,Up,0.325566413378878,0.93082651113838
286,WP_HISTONE_MODIFICATIONS,37,Down,0.325919993669709,0.93082651113838
287,WP_VITAMIN_D_RECEPTOR_PATHWAY,81,Up,0.325949128403873,0.93082651113838
288,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,21,Up,0.326128996603228,0.93082651113838
289,WP_GABA_METABOLISM_AKA_GHB,4,Up,0.327373202843024,0.931144542342441
290,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,11,Down,0.328992795576261,0.932524406771333
291,WP_GPCRS_CLASS_A_RHODOPSINLIKE,40,Up,0.333102090653582,0.934515725190245
292,WP_ARYLAMINE_METABOLISM,1,Up,0.333858002718699,0.934515725190245
293,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Down,0.334113812578475,0.934515725190245
294,WP_NEPHROTIC_SYNDROME,27,Up,0.334683965925,0.934515725190245
295,WP_PHOSPHOINOSITIDES_METABOLISM,38,Down,0.338149043362193,0.934515725190245
296,WP_GLUCURONIDATION,7,Up,0.339510846138338,0.934515725190245
297,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Down,0.339523521932122,0.934515725190245
298,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Down,0.339669312546655,0.934515725190245
299,WP_SEROTONIN_TRANSPORTER_ACTIVITY,4,Up,0.341151468657212,0.934515725190245
300,WP_DNA_REPLICATION,35,Down,0.342716148671544,0.934515725190245
301,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,20,Up,0.344339050345259,0.934515725190245
302,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,12,Up,0.344492527395706,0.934515725190245
303,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,30,Down,0.345922635786354,0.934515725190245
304,WP_CELLULAR_PROTEOSTASIS,6,Up,0.347093247092903,0.934515725190245
305,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,46,Up,0.347217497056366,0.934515725190245
306,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,20,Down,0.349483225194618,0.934515725190245
307,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,23,Up,0.349716680126059,0.934515725190245
308,WP_ATM_SIGNALING,34,Down,0.353195367099933,0.934515725190245
309,WP_IL26_SIGNALING,31,Up,0.353342743962098,0.934515725190245
310,WP_WNT_SIGNALING_WP363,36,Up,0.353527386031817,0.934515725190245
311,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Down,0.355698310065833,0.934515725190245
312,WP_THIAMINE_METABOLIC_PATHWAYS,9,Down,0.357399193701028,0.934515725190245
313,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,15,Down,0.359106095615823,0.934515725190245
314,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,38,Up,0.359482049313136,0.934515725190245
315,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,30,Up,0.361008261736045,0.934515725190245
316,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Down,0.363184608336928,0.934515725190245
317,WP_MATRIX_METALLOPROTEINASES,8,Down,0.363547505170104,0.934515725190245
318,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Up,0.363870651963424,0.934515725190245
319,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Down,0.363946849199527,0.934515725190245
320,WP_ID_SIGNALING,12,Down,0.367300599460565,0.934515725190245
321,WP_ESTROGEN_METABOLISM_WP5276,8,Down,0.367985170565702,0.934515725190245
322,WP_OXIDATION_BY_CYTOCHROME_P450,14,Up,0.370118841660462,0.934515725190245
323,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Down,0.370780740476222,0.934515725190245
324,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,21,Up,0.370855514985083,0.934515725190245
325,WP_METHYLATION_PATHWAYS,5,Up,0.371229577743286,0.934515725190245
326,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,21,Up,0.373139419799331,0.934515725190245
327,WP_CAMKK2_PATHWAY,29,Up,0.376269123288419,0.934515725190245
328,WP_BENZOAPYRENE_METABOLISM,5,Down,0.376856306050081,0.934515725190245
329,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,12,Up,0.37711908958005,0.934515725190245
330,WP_ACUTE_VIRAL_MYOCARDITIS,64,Up,0.378263622526124,0.934515725190245
331,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Up,0.381850236886289,0.934515725190245
332,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Up,0.381860663827718,0.934515725190245
333,WP_G_PROTEIN_SIGNALING,61,Up,0.382948586845812,0.934515725190245
334,WP_NEOVASCULARIZATION_PROCESSES,22,Up,0.384820091908389,0.934515725190245
335,WP_CYTOSINE_METHYLATION,7,Up,0.385308588304092,0.934515725190245
336,WP_HIPPO_SIGNALING_REGULATION,43,Up,0.386503690539647,0.934515725190245
337,WP_LEUKOTRIENE_METABOLIC_PATHWAY,8,Up,0.387651784411066,0.934515725190245
338,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Down,0.387979625559786,0.934515725190245
339,WP_NRXN1_DELETION_SYNDROME,2,Down,0.389489105485575,0.934515725190245
340,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,271,Up,0.390155120027188,0.934515725190245
341,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,37,Up,0.391447656226479,0.934515725190245
342,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,46,Up,0.391741155617082,0.934515725190245
343,WP_REGULATION_OF_ACTIN_CYTOSKELETON,92,Up,0.392349516309902,0.934515725190245
344,WP_LUNG_FIBROSIS,32,Up,0.395306282772024,0.934515725190245
345,WP_CANNABINOID_RECEPTOR_SIGNALING,16,Down,0.39640614320139,0.934515725190245
346,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,9,Up,0.398542690107412,0.934515725190245
347,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,9,Up,0.399358331760782,0.934515725190245
348,WP_NUCLEOTIDE_GPCRS,5,Up,0.400036492860051,0.934515725190245
349,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Up,0.401241138042471,0.934515725190245
350,WP_TNFALPHA_SIGNALING,82,Up,0.40194661944011,0.934515725190245
351,WP_MITOCHONDRIAL_BETAOXIDATION,8,Up,0.402670851050336,0.934515725190245
352,WP_GPCRS_CLASS_B_SECRETINLIKE,4,Down,0.402779850279589,0.934515725190245
353,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,43,Up,0.404853931670604,0.934515725190245
354,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,38,Up,0.405618534104112,0.934515725190245
355,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,15,Down,0.405810923209963,0.934515725190245
356,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,25,Down,0.406810874625571,0.934515725190245
357,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,14,Down,0.406948143777737,0.934515725190245
358,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,33,Down,0.408044436792627,0.934515725190245
359,WP_WNT_SIGNALING_WP428,58,Up,0.412271576315191,0.934515725190245
360,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Up,0.415363043197092,0.934515725190245
361,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,46,Up,0.418069296928833,0.934515725190245
362,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,16,Down,0.420477474270421,0.934515725190245
363,WP_CALORIC_RESTRICTION_AND_AGING,7,Down,0.42134699952327,0.934515725190245
364,WP_LIPID_PARTICLES_COMPOSITION,5,Down,0.421456773498052,0.934515725190245
365,WP_FLUOROACETIC_ACID_TOXICITY,6,Down,0.421483567883434,0.934515725190245
366,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Down,0.422290483910006,0.934515725190245
367,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,37,Up,0.422292266314867,0.934515725190245
368,WP_MIRNA_BIOGENESIS,6,Up,0.422860801519785,0.934515725190245
369,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,73,Up,0.423994307052179,0.934515725190245
370,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,21,Up,0.424449660632167,0.934515725190245
371,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,45,Down,0.42491750065684,0.934515725190245
372,WP_IL1_SIGNALING,51,Up,0.425218959981412,0.934515725190245
373,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,28,Up,0.425337129285859,0.934515725190245
374,WP_PRION_DISEASE_PATHWAY,28,Up,0.425495196239338,0.934515725190245
375,WP_FRAGILE_X_SYNDROME,83,Up,0.426330166601389,0.934515725190245
376,WP_NEURAL_CREST_DIFFERENTIATION,39,Up,0.428689665929294,0.934699187340001
377,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,5,Up,0.433708752885699,0.934699187340001
378,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,9,Up,0.433898716977407,0.934699187340001
379,WP_G1_TO_S_CELL_CYCLE_CONTROL,50,Down,0.433952401167591,0.934699187340001
380,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Down,0.434036501951488,0.934699187340001
381,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,9,Up,0.434327474690893,0.934699187340001
382,WP_DISORDERS_IN_KETOLYSIS,4,Up,0.434604587915832,0.934699187340001
383,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,15,Down,0.437040532929059,0.934699187340001
384,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,13,Up,0.437514373254013,0.934699187340001
385,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Up,0.437784899179928,0.934699187340001
386,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Up,0.441990841870312,0.938518993497618
387,WP_LUNG_PATHOLOGY_OF_COVID19,13,Down,0.444805153532533,0.938518993497618
388,WP_TYPE_II_DIABETES_MELLITUS,14,Down,0.446463451786682,0.938518993497618
389,WP_TGFBETA_RECEPTOR_SIGNALING,35,Up,0.447772007466842,0.938518993497618
390,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Up,0.452182579941865,0.938518993497618
391,WP_IL2_SIGNALING,37,Up,0.45496165333282,0.938518993497618
392,WP_16P112_DISTAL_DELETION_SYNDROME,20,Down,0.45496870550799,0.938518993497618
393,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,26,Up,0.455391180640186,0.938518993497618
394,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,10,Up,0.457789449352306,0.938518993497618
395,WP_IL4_SIGNALING,50,Up,0.45991460127931,0.938518993497618
396,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Up,0.46012620386026,0.938518993497618
397,WP_FATTY_ACID_BETAOXIDATION,29,Down,0.460592742981085,0.938518993497618
398,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,79,Up,0.461170293309831,0.938518993497618
399,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,10,Down,0.461429877923389,0.938518993497618
400,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Up,0.461523045342287,0.938518993497618
401,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,10,Up,0.462183190501539,0.938518993497618
402,WP_KININKALLIKREIN_PATHWAY,2,Up,0.462721499958033,0.938518993497618
403,WP_5Q35_COPY_NUMBER_VARIATION,76,Up,0.464819975636133,0.938518993497618
404,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,17,Down,0.465883421197551,0.938518993497618
405,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,46,Up,0.4676321885232,0.938518993497618
406,WP_ERBB_SIGNALING,67,Down,0.468386144632831,0.938518993497618
407,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,13,Up,0.46876385893929,0.938518993497618
408,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,51,Up,0.469273742299166,0.938518993497618
409,WP_OXIDATIVE_PHOSPHORYLATION,50,Up,0.47142795272597,0.938518993497618
410,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,24,Down,0.47182645651497,0.938518993497618
411,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,40,Down,0.472747417483383,0.938518993497618
412,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,30,Up,0.474422544619748,0.938518993497618
413,WP_POSTCOVID_NEUROINFLAMMATION,11,Up,0.474936809134575,0.938518993497618
414,WP_HIPPOYAP_SIGNALING,16,Up,0.47571714612349,0.938518993497618
415,WP_CHEMOKINE_SIGNALING,108,Up,0.476554836943049,0.938518993497618
416,WP_B_CELL_RECEPTOR_SIGNALING,83,Down,0.476651695228776,0.938518993497618
417,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Up,0.480364858260782,0.938518993497618
418,WP_IL5_SIGNALING,37,Up,0.481151514972084,0.938518993497618
419,WP_LEPTIN_AND_ADIPONECTIN,8,Up,0.482309533971791,0.938518993497618
420,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Down,0.48275941363518,0.938518993497618
421,WP_ONCOSTATIN_M_SIGNALING,53,Up,0.483170963911295,0.938518993497618
422,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,3,Up,0.485524381365742,0.938518993497618
423,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Down,0.485987482323887,0.938518993497618
424,WP_ESTROGEN_METABOLISM_WP697,5,Up,0.486981098072658,0.938518993497618
425,WP_IDO_METABOLIC_PATHWAY,7,Up,0.491493646923555,0.938518993497618
426,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,60,Up,0.492233106458848,0.938518993497618
427,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Up,0.492318879052854,0.938518993497618
428,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,9,Down,0.49549542096936,0.938518993497618
429,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,39,Down,0.496763265981619,0.938518993497618
430,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,15,Down,0.500683485706099,0.938518993497618
431,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Up,0.501915775149055,0.938518993497618
432,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Up,0.502245327299888,0.938518993497618
433,WP_KIT_RECEPTOR_SIGNALING,49,Down,0.502321390246316,0.938518993497618
434,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Up,0.502651194065174,0.938518993497618
435,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Up,0.503417214277703,0.938518993497618
436,WP_LEPTININSULIN_SIGNALING_OVERLAP,13,Down,0.504579418341041,0.938518993497618
437,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,39,Down,0.505710506228085,0.938518993497618
438,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Down,0.50631133135529,0.938518993497618
439,WP_METABOLIC_EPILEPTIC_DISORDERS,57,Up,0.506639789193278,0.938518993497618
440,WP_IL18_SIGNALING,186,Up,0.507105165179287,0.938518993497618
441,WP_EBOLA_VIRUS_INFECTION_IN_HOST,105,Up,0.507520748325882,0.938518993497618
442,WP_BARDETBIEDL_SYNDROME,65,Down,0.50773180339835,0.938518993497618
443,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Down,0.508116222200042,0.938518993497618
444,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,3,Down,0.50858879810924,0.938518993497618
445,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,131,Up,0.510072357820302,0.938518993497618
446,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,4,Up,0.511053700711899,0.938518993497618
447,WP_LEPTIN_SIGNALING,69,Up,0.511059227360014,0.938518993497618
448,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Down,0.511504268962205,0.938518993497618
449,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Down,0.513155696541265,0.939452076964187
450,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Up,0.514591683867379,0.939987475864413
451,WP_IL10_ANTIINFLAMMATORY_SIGNALING,10,Up,0.519318980097898,0.946280170762157
452,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,82,Down,0.520985476190484,0.946280170762157
453,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,41,Up,0.521490167098853,0.946280170762157
454,WP_ALZHEIMERS_DISEASE,183,Up,0.524560386590539,0.947667335774557
455,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,183,Up,0.524560386590539,0.947667335774557
456,WP_NGLYCAN_BIOSYNTHESIS,52,Up,0.528191461446679,0.952134608134145
457,WP_IL11_SIGNALING,40,Up,0.533898265730719,0.954079902142774
458,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,8,Down,0.534006223049517,0.954079902142774
459,WP_UROTENSINIIMEDIATED_SIGNALING,48,Up,0.534083630444797,0.954079902142774
460,WP_EGFEGFR_SIGNALING,136,Up,0.536669338525015,0.954079902142774
461,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,27,Up,0.538953447786503,0.954079902142774
462,WP_TP53_NETWORK,16,Down,0.540784040099645,0.954079902142774
463,WP_KCNQ2RELATED_EPILEPSIES,11,Down,0.542339241184526,0.954079902142774
464,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,12,Up,0.546018004632509,0.954079902142774
465,WP_BREAST_CANCER_PATHWAY,87,Up,0.546471757168765,0.954079902142774
466,WP_NANOMATERIAL_INDUCED_APOPTOSIS,18,Up,0.547394805976978,0.954079902142774
467,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Up,0.550508510967737,0.954079902142774
468,WP_IL7_SIGNALING,23,Up,0.550599525192589,0.954079902142774
469,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,8,Up,0.551207917709311,0.954079902142774
470,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Up,0.551662430206406,0.954079902142774
471,WP_OMEGA9_FATTY_ACID_SYNTHESIS,11,Up,0.551733941676151,0.954079902142774
472,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Up,0.555516613458517,0.954079902142774
473,WP_ANDROGEN_RECEPTOR_SIGNALING,77,Up,0.556528456456313,0.954079902142774
474,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Up,0.557972134968168,0.954079902142774
475,WP_FLUOROPYRIMIDINE_ACTIVITY,25,Up,0.55864671960349,0.954079902142774
476,WP_ADIPOGENESIS,86,Down,0.558852723399156,0.954079902142774
477,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Down,0.559682976282608,0.954079902142774
478,WP_MRNA_PROCESSING,124,Up,0.560464266825404,0.954079902142774
479,WP_ULCERATIVE_COLITIS_SIGNALING,12,Up,0.560708759131205,0.954079902142774
480,WP_CILIARY_LANDSCAPE,184,Up,0.562078207007334,0.954079902142774
481,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Up,0.56296120759018,0.954079902142774
482,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Down,0.565488766595159,0.954079902142774
483,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,50,Up,0.567132475581121,0.954079902142774
484,WP_VALPROIC_ACID_PATHWAY,9,Up,0.567898446377507,0.954079902142774
485,WP_RALA_DOWNSTREAM_REGULATED_GENES,12,Up,0.568254243343596,0.954079902142774
486,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Down,0.568708019993655,0.954079902142774
487,WP_HEME_BIOSYNTHESIS,8,Down,0.568708019993655,0.954079902142774
488,WP_MESODERMAL_COMMITMENT_PATHWAY,76,Down,0.570207863436059,0.954079902142774
489,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,43,Down,0.570946236833785,0.954079902142774
490,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,10,Up,0.57165931319696,0.954079902142774
491,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,19,Down,0.572513182066027,0.954079902142774
492,WP_OPIOID_RECEPTOR_PATHWAYS,25,Up,0.572580649267919,0.954079902142774
493,WP_SPINAL_CORD_INJURY,64,Up,0.575171006589871,0.954079902142774
494,WP_INTEGRINMEDIATED_CELL_ADHESION,72,Up,0.575286894697283,0.954079902142774
495,WP_INCLUSION_BODY_MYOSITIS,9,Down,0.580010875529809,0.954079902142774
496,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,83,Up,0.580268100176864,0.954079902142774
497,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,7,Up,0.580896852393523,0.954079902142774
498,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,17,Down,0.581896732862205,0.954079902142774
499,WP_PEPTIDE_GPCRS,13,Up,0.582185551466043,0.954079902142774
500,WP_SYNAPTIC_VESICLE_PATHWAY,21,Up,0.58227221097461,0.954079902142774
501,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,10,Up,0.583263756000298,0.954079902142774
502,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Up,0.583985881403935,0.954079902142774
503,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,125,Up,0.584768569701002,0.954079902142774
504,WP_PILOCYTIC_ASTROCYTOMA,6,Down,0.585325536575791,0.954079902142774
505,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Up,0.587073677274825,0.954079902142774
506,WP_IRON_METABOLISM_DISORDERS,10,Down,0.587304659956501,0.954079902142774
507,WP_NOTCH_SIGNALING_WP61,49,Up,0.590800811252797,0.956020518441915
508,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,10,Down,0.591461291144843,0.956020518441915
509,WP_ENDOMETRIAL_CANCER,49,Up,0.591988374558315,0.956020518441915
510,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,13,Up,0.593757595137804,0.95661884572283
511,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,113,Down,0.594686411392173,0.95661884572283
512,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,19,Down,0.597779506162057,0.959510026517703
513,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Up,0.598818301220902,0.959510026517703
514,WP_CILIOPATHIES,127,Down,0.607436917903294,0.970205216825573
515,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Down,0.607853633412616,0.970205216825573
516,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,30,Up,0.611177933813757,0.972531821718224
517,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,9,Up,0.612236866655445,0.972531821718224
518,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,8,Down,0.613205773260621,0.972531821718224
519,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,15,Down,0.614043814442528,0.972531821718224
520,WP_PLEURAL_MESOTHELIOMA,248,Up,0.615236186965209,0.972546434010389
521,WP_SULFATASE_AND_AROMATASE_PATHWAY,2,Down,0.619758096523823,0.97442521217427
522,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,57,Up,0.619975087561009,0.97442521217427
523,WP_MTHFR_DEFICIENCY,18,Up,0.619981004826208,0.97442521217427
524,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,62,Up,0.62218448567696,0.976022227531415
525,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,11,Up,0.623669234896064,0.976487830637265
526,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,35,Up,0.62745942101912,0.978043557066633
527,WP_DOPAMINERGIC_NEUROGENESIS,4,Up,0.628035215125686,0.978043557066633
528,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Down,0.629718479161498,0.978043557066633
529,WP_ENDOTHELIN_PATHWAYS,12,Down,0.633276096536678,0.978043557066633
530,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,57,Up,0.633891055569419,0.978043557066633
531,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Up,0.636116939712312,0.978043557066633
532,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,11,Up,0.637333345039314,0.978043557066633
533,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Down,0.63788429135643,0.978043557066633
534,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Down,0.638109816263217,0.978043557066633
535,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,72,Up,0.638185219842168,0.978043557066633
536,WP_PARKINSONS_DISEASE_PATHWAY,26,Up,0.640847531353604,0.978043557066633
537,WP_AXON_GUIDANCE,37,Up,0.641873214297218,0.978043557066633
538,WP_13Q1212_COPY_NUMBER_VARIATION,20,Up,0.642332855822245,0.978043557066633
539,WP_KETOGENESIS_AND_KETOLYSIS,6,Down,0.642955839806526,0.978043557066633
540,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,13,Up,0.643435572141982,0.978043557066633
541,WP_NPHP1_DELETION_SYNDROME,10,Up,0.644379139131273,0.978043557066633
542,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,11,Up,0.644890033978242,0.978043557066633
543,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,3,Up,0.647665234386932,0.980443503989058
544,WP_FATTY_ACID_OMEGAOXIDATION,2,Up,0.652844753147305,0.983633457601839
545,WP_ASPIRIN_AND_MIRNAS,8,Up,0.657255699255526,0.983633457601839
546,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,45,Up,0.658793866235314,0.983633457601839
547,WP_GALANIN_RECEPTOR_PATHWAY,10,Down,0.65947417907379,0.983633457601839
548,WP_GENES_CONTROLLING_NEPHROGENESIS,13,Up,0.659878788482617,0.983633457601839
549,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,20,Down,0.661537994648416,0.983633457601839
550,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Down,0.66261890642125,0.983633457601839
551,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,3,Up,0.663352058092402,0.983633457601839
552,WP_TLR4_SIGNALING_AND_TOLERANCE,26,Up,0.664477544969185,0.983633457601839
553,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,21,Up,0.664515053738627,0.983633457601839
554,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Up,0.665582668352736,0.983633457601839
555,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,9,Down,0.666939828903955,0.983633457601839
556,WP_TAR_SYNDROME,43,Down,0.667318439800022,0.983633457601839
557,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Up,0.667515189805175,0.983633457601839
558,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,19,Up,0.667721982167672,0.983633457601839
559,WP_P38_MAPK_SIGNALING,31,Up,0.670036751642672,0.984283207112316
560,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Down,0.671645940807015,0.984283207112316
561,WP_IL9_SIGNALING,15,Up,0.671755327481763,0.984283207112316
562,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,40,Up,0.675401015715589,0.98535149959436
563,WP_VITAMIN_D_METABOLISM,6,Up,0.676871172024117,0.98535149959436
564,WP_TRANSLATION_FACTORS,49,Up,0.677259518147584,0.98535149959436
565,WP_INTEGRATED_CANCER_PATHWAY,40,Down,0.677782106630573,0.98535149959436
566,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,5,Up,0.678478039866676,0.98535149959436
567,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,20,Down,0.683923077151168,0.988955523495946
568,WP_TYPE_II_INTERFERON_SIGNALING,30,Up,0.684283587900647,0.988955523495946
569,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,3,Up,0.685556709385368,0.988955523495946
570,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Down,0.687228469667102,0.988955523495946
571,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Down,0.690178820207031,0.988955523495946
572,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,62,Down,0.691912774715952,0.988955523495946
573,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,3,Down,0.693037619867599,0.988955523495946
574,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,55,Up,0.694120960620192,0.988955523495946
575,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,3,Up,0.695268219331954,0.988955523495946
576,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,10,Down,0.696985885656531,0.988955523495946
577,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,88,Down,0.697205715007625,0.988955523495946
578,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,4,Down,0.701898344437871,0.988955523495946
579,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,16,Down,0.702495922441116,0.988955523495946
580,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Up,0.703089618358186,0.988955523495946
581,WP_SLEEP_REGULATION,11,Up,0.709404831331461,0.988955523495946
582,WP_PYRIMIDINE_METABOLISM,71,Down,0.71035030070658,0.988955523495946
583,WP_KALLMANN_SYNDROME,11,Up,0.710961320692556,0.988955523495946
584,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Down,0.711376677437125,0.988955523495946
585,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,60,Up,0.713210154902672,0.988955523495946
586,WP_IL17_SIGNALING,25,Down,0.713851689155145,0.988955523495946
587,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,60,Up,0.715148462963017,0.988955523495946
588,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,30,Up,0.716011445295027,0.988955523495946
589,WP_COMPLEMENT_AND_COAGULATION_CASCADES,23,Down,0.716505092476213,0.988955523495946
590,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,23,Down,0.716505092476213,0.988955523495946
591,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,7,Up,0.716557806656755,0.988955523495946
592,WP_ENDODERM_DIFFERENTIATION,81,Up,0.7177354054528,0.988955523495946
593,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,50,Down,0.718037148790605,0.988955523495946
594,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,21,Up,0.718912419969498,0.988955523495946
595,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Down,0.719807329905867,0.988955523495946
596,WP_JOUBERT_SYNDROME,71,Up,0.719832760644885,0.988955523495946
597,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Up,0.722391355920327,0.988955523495946
598,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,20,Down,0.722493617646564,0.988955523495946
599,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,47,Up,0.722684842129464,0.988955523495946
600,WP_NETRINUNC5B_SIGNALING,34,Down,0.723713227063464,0.988955523495946
601,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,17,Up,0.725424355404431,0.988955523495946
602,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,12,Up,0.726267052591268,0.988955523495946
603,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,30,Up,0.726436470031972,0.988955523495946
604,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,3,Up,0.726677781254929,0.988955523495946
605,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,44,Up,0.728150298940274,0.989321563188273
606,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,2,Up,0.731660272663463,0.990832906287739
607,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,35,Down,0.731673447830484,0.990832906287739
608,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,7,Down,0.733038872738672,0.991049265446034
609,WP_SULINDAC_METABOLIC_PATHWAY,2,Down,0.739779638486745,0.995790115490268
610,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,20,Up,0.741827728390709,0.995790115490268
611,WP_DRAVET_SYNDROME,13,Up,0.743201921803032,0.995790115490268
612,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,32,Up,0.743933741847188,0.995790115490268
613,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,15,Up,0.746719383093063,0.995790115490268
614,WP_GDNFRET_SIGNALING_AXIS,4,Down,0.747010454152979,0.995790115490268
615,WP_METASTATIC_BRAIN_TUMOR,5,Up,0.752496070251485,0.995790115490268
616,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Up,0.75429406178409,0.995790115490268
617,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,6,Up,0.755334319821559,0.995790115490268
618,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Down,0.755514157763962,0.995790115490268
619,WP_BASE_EXCISION_REPAIR,29,Down,0.756997583844237,0.995790115490268
620,WP_NAD_METABOLISM,12,Down,0.758409557070073,0.995790115490268
621,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,1,Up,0.760905112708999,0.995790115490268
622,WP_COMPLEMENT_SYSTEM,49,Down,0.760965240665205,0.995790115490268
623,WP_WHITE_FAT_CELL_DIFFERENTIATION,23,Up,0.763120152210222,0.995790115490268
624,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,90,Down,0.763745227018981,0.995790115490268
625,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,7,Up,0.764669243632285,0.995790115490268
626,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Down,0.76570525778326,0.995790115490268
627,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Up,0.766121057707929,0.995790115490268
628,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,73,Up,0.766176998075203,0.995790115490268
629,WP_INSULIN_SIGNALING,128,Down,0.767020787760148,0.995790115490268
630,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,47,Down,0.768308473902512,0.995790115490268
631,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,12,Down,0.772802950980114,0.995790115490268
632,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,85,Down,0.773786179361767,0.995790115490268
633,WP_GABA_RECEPTOR_SIGNALING,10,Up,0.775419162637509,0.995790115490268
634,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,13,Down,0.775980155190108,0.995790115490268
635,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Up,0.776442907074108,0.995790115490268
636,WP_IL6_SIGNALING,38,Up,0.777919360443221,0.995790115490268
637,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Down,0.778824051120086,0.995790115490268
638,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,40,Up,0.781041612653592,0.995790115490268
639,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,16,Down,0.782454146395964,0.995790115490268
640,WP_GLYCOSPHINGOLIPID_METABOLISM,12,Down,0.785091553582517,0.995790115490268
641,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Down,0.78602065872058,0.995790115490268
642,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,165,Up,0.786600889387804,0.995790115490268
643,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,7,Down,0.787735615899351,0.995790115490268
644,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Up,0.787962912702421,0.995790115490268
645,WP_TOLLLIKE_RECEPTOR_SIGNALING,79,Down,0.788370360181613,0.995790115490268
646,WP_LIPID_METABOLISM_PATHWAY,23,Down,0.790921045118535,0.995790115490268
647,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,76,Up,0.793221121717344,0.995790115490268
648,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,15,Up,0.794567786699448,0.995790115490268
649,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,105,Up,0.796607488139956,0.995790115490268
650,WP_MAPK_CASCADE,30,Down,0.797261945915898,0.995790115490268
651,WP_BENZENE_METABOLISM,3,Up,0.798117298661532,0.995790115490268
652,WP_PROTEASOME_DEGRADATION,57,Up,0.798630819739026,0.995790115490268
653,WP_TRYPTOPHAN_METABOLISM,18,Down,0.799089993888109,0.995790115490268
654,WP_BURN_WOUND_HEALING,57,Up,0.800810780499534,0.995790115490268
655,WP_OREXIN_RECEPTOR_PATHWAY,116,Down,0.801261909495789,0.995790115490268
656,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Up,0.802372427606307,0.995790115490268
657,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,16,Up,0.803576263873301,0.995790115490268
658,WP_GPCRS_OTHER,10,Down,0.806955899833551,0.995790115490268
659,WP_TCELL_RECEPTOR_SIGNALING,71,Up,0.810818471690948,0.995790115490268
660,WP_APOPTOSIS_MODULATION_AND_SIGNALING,78,Down,0.815268907345277,0.995790115490268
661,WP_PRIMARY_OVARIAN_INSUFFICIENCY,86,Down,0.81844534971222,0.995790115490268
662,WP_KLEEFSTRA_SYNDROME,25,Down,0.819136618458059,0.995790115490268
663,WP_UREA_CYCLE_AND_RELATED_DISEASES,3,Down,0.820372982730839,0.995790115490268
664,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,15,Down,0.822752761349037,0.995790115490268
665,WP_RAS_SIGNALING,114,Up,0.824372752513512,0.995790115490268
666,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,6,Up,0.824693359767242,0.995790115490268
667,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,22,Down,0.824740148434871,0.995790115490268
668,WP_CARDIAC_HYPERTROPHIC_RESPONSE,44,Up,0.827566469563256,0.995790115490268
669,WP_STEROID_BIOSYNTHESIS,2,Down,0.827804354029379,0.995790115490268
670,WP_HUNGER_AND_SATIETY,2,Down,0.82914613597262,0.995790115490268
671,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,29,Up,0.830633053744212,0.995790115490268
672,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,14,Down,0.832318225907615,0.995790115490268
673,WP_CELL_CYCLE,92,Down,0.832362016081908,0.995790115490268
674,WP_HEDGEHOG_SIGNALING_WP4249,24,Down,0.835248595534229,0.995790115490268
675,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,65,Down,0.836574961447046,0.995790115490268
676,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,13,Up,0.839304976217498,0.995790115490268
677,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Down,0.839599493605369,0.995790115490268
678,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Up,0.839957857473551,0.995790115490268
679,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Down,0.840622456030772,0.995790115490268
680,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,31,Up,0.842020553274294,0.995790115490268
681,WP_AUTOPHAGY,27,Down,0.842537293728536,0.995790115490268
682,WP_OSTEOPONTIN_SIGNALING,11,Down,0.844342238184102,0.995790115490268
683,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,27,Down,0.84506624003072,0.995790115490268
684,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,11,Up,0.846140587417359,0.995790115490268
685,WP_RETT_SYNDROME,31,Down,0.846861196688041,0.995790115490268
686,WP_TCELL_ACTIVATION_SARSCOV2,60,Down,0.847483603485274,0.995790115490268
687,WP_MAPK_SIGNALING,162,Up,0.849721205107452,0.995790115490268
688,WP_ALSTROM_SYNDROME,27,Up,0.8504692830831,0.995790115490268
689,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,51,Up,0.852226222821882,0.995790115490268
690,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,30,Up,0.853442381795095,0.995790115490268
691,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,19,Up,0.857560646671771,0.995790115490268
692,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,14,Up,0.860316279913635,0.995790115490268
693,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,4,Up,0.860702808544632,0.995790115490268
694,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Down,0.861412183886289,0.995790115490268
695,WP_ENERGY_METABOLISM,41,Up,0.865565966142654,0.995790115490268
696,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,85,Up,0.866564830773139,0.995790115490268
697,WP_GASTRIC_CANCER_NETWORK_2,24,Down,0.866776827803951,0.995790115490268
698,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,18,Down,0.867823106485348,0.995790115490268
699,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Up,0.86814289002428,0.995790115490268
700,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Down,0.868169191141035,0.995790115490268
701,WP_TRIACYLGLYCERIDE_SYNTHESIS,18,Up,0.868928614245452,0.995790115490268
702,WP_FOXA2_PATHWAY,9,Up,0.873202221861325,0.995790115490268
703,WP_6Q16_COPY_NUMBER_VARIATION,5,Down,0.874176855347752,0.995790115490268
704,WP_VITAMIN_B12_DISORDERS,9,Up,0.874385893254616,0.995790115490268
705,WP_AFLATOXIN_B1_METABOLISM,2,Up,0.875383191263133,0.995790115490268
706,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,33,Down,0.878181429880723,0.995790115490268
707,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,2,Up,0.878503435125623,0.995790115490268
708,WP_FATTY_ACID_BIOSYNTHESIS,21,Up,0.879445269050287,0.995790115490268
709,WP_OXIDATIVE_DAMAGE_RESPONSE,32,Down,0.880491423474044,0.995790115490268
710,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,13,Down,0.880528989817069,0.995790115490268
711,WP_PI3KAKT_SIGNALING,176,Up,0.881581434271573,0.995790115490268
712,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Up,0.882903595923544,0.995790115490268
713,WP_BDNFTRKB_SIGNALING,26,Down,0.883827436430638,0.995790115490268
714,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Up,0.885423793268408,0.995790115490268
715,WP_OSTEOBLAST_SIGNALING,3,Up,0.889716728378321,0.995790115490268
716,WP_MELATONIN_METABOLISM_AND_EFFECTS,19,Up,0.892238266656411,0.995790115490268
717,WP_TCA_CYCLE_IN_SENESCENCE,10,Down,0.892830724366936,0.995790115490268
718,WP_MITOCHONDRIAL_GENE_EXPRESSION,16,Up,0.893966600117679,0.995790115490268
719,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Up,0.898436432103178,0.995790115490268
720,WP_15Q25_COPY_NUMBER_VARIATION,28,Down,0.89915318350413,0.995790115490268
721,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,12,Up,0.899732214680142,0.995790115490268
722,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Up,0.901042865073268,0.995790115490268
723,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,23,Down,0.904518631123448,0.995790115490268
724,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,63,Up,0.906199920596258,0.995790115490268
725,WP_MELANOMA,53,Down,0.906246494744806,0.995790115490268
726,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,22,Up,0.906262532943409,0.995790115490268
727,WP_PROTEOGLYCAN_BIOSYNTHESIS,15,Up,0.906893364507015,0.995790115490268
728,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,55,Up,0.907083063206435,0.995790115490268
729,WP_CORI_CYCLE,11,Down,0.907479094412303,0.995790115490268
730,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Down,0.909156367364901,0.995790115490268
731,WP_KREBS_CYCLE_DISORDERS,11,Up,0.909583683804111,0.995790115490268
732,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Up,0.911323358417871,0.995790115490268
733,WP_NUCLEOTIDE_EXCISION_REPAIR,43,Up,0.911530100756015,0.995790115490268
734,WP_FERROPTOSIS,50,Up,0.911870480816288,0.995790115490268
735,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Down,0.912560056440179,0.995790115490268
736,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,70,Up,0.91418811016876,0.995790115490268
737,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,3,Up,0.916338452358112,0.995790115490268
738,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Down,0.917324927114508,0.995790115490268
739,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,34,Up,0.917331356560959,0.995790115490268
740,WP_AEROBIC_GLYCOLYSIS,10,Down,0.918660064136311,0.995790115490268
741,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,10,Down,0.918660064136311,0.995790115490268
742,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Up,0.919203062473218,0.995790115490268
743,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,170,Down,0.920075043494434,0.995790115490268
744,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,11,Up,0.920587870410748,0.995790115490268
745,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,7,Up,0.920865464442071,0.995790115490268
746,WP_MONOAMINE_TRANSPORT,12,Down,0.921818818118596,0.995790115490268
747,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Down,0.922237836045172,0.995790115490268
748,WP_NEPHROGENESIS,4,Up,0.922378163871642,0.995790115490268
749,WP_4P163_COPY_NUMBER_VARIATION,21,Up,0.924148080145949,0.995790115490268
750,WP_OSTEOCLAST_SIGNALING,9,Up,0.924830656491458,0.995790115490268
751,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,11,Down,0.925813342354181,0.995790115490268
752,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,27,Up,0.926016802892737,0.995790115490268
753,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,6,Down,0.926112406969414,0.995790115490268
754,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Down,0.926666864656793,0.995790115490268
755,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,2,Up,0.926682834877481,0.995790115490268
756,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,13,Up,0.927509903385312,0.995790115490268
757,WP_EFFECTS_OF_MFN2_MUTATION,17,Up,0.927511602065508,0.995790115490268
758,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Down,0.931420518113,0.995790115490268
759,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Down,0.933490985526027,0.995790115490268
760,WP_HEDGEHOG_SIGNALING_WP47,6,Down,0.936244967657544,0.995790115490268
761,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Up,0.936953954628811,0.995790115490268
762,WP_GLIAL_CELL_DIFFERENTIATION,4,Down,0.93757714458413,0.995790115490268
763,WP_EICOSANOID_SYNTHESIS,13,Down,0.940020829907195,0.995790115490268
764,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,60,Up,0.940877256861456,0.995790115490268
765,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,24,Up,0.94106236606236,0.995790115490268
766,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,34,Down,0.941403879898579,0.995790115490268
767,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Up,0.942152608805615,0.995790115490268
768,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,19,Up,0.942455932561705,0.995790115490268
769,WP_OVARIAN_INFERTILITY,20,Up,0.944276934072196,0.995790115490268
770,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,23,Up,0.945180190782395,0.995790115490268
771,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Down,0.945216080302561,0.995790115490268
772,WP_NAD_BIOSYNTHETIC_PATHWAYS,19,Up,0.946729714053765,0.995790115490268
773,WP_CYTOSOLIC_DNASENSING_PATHWAY,53,Down,0.94742864051378,0.995790115490268
774,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,8,Up,0.948962435527945,0.995790115490268
775,WP_ETHER_LIPID_BIOSYNTHESIS,16,Up,0.950137854593693,0.995790115490268
776,WP_AMINO_ACID_METABOLISM,59,Up,0.950802580731081,0.995790115490268
777,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,13,Down,0.951576140159114,0.995790115490268
778,WP_CIRCADIAN_RHYTHM_GENES,119,Down,0.953528870492975,0.995790115490268
779,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,4,Down,0.953889059542036,0.995790115490268
780,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,4,Down,0.955182032168578,0.995790115490268
781,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,18,Down,0.957259125572137,0.995790115490268
782,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Down,0.957503286914239,0.995790115490268
783,WP_VITAMIN_A1_AND_A5X_PATHWAYS,3,Up,0.958737176647309,0.995790115490268
784,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Up,0.958759919121734,0.995790115490268
785,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Down,0.960330760940095,0.995790115490268
786,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,17,Down,0.961152437261176,0.995790115490268
787,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,14,Down,0.961600214807471,0.995790115490268
788,WP_ACE_INHIBITOR_PATHWAY,5,Up,0.962958951481561,0.995790115490268
789,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,17,Up,0.964610988829136,0.995790115490268
790,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,7,Up,0.965383473791889,0.995790115490268
791,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,37,Up,0.966115153494782,0.995790115490268
792,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Up,0.966731762462075,0.995790115490268
793,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.967940088077848,0.995790115490268
794,WP_BLADDER_CANCER,29,Up,0.968007097978339,0.995790115490268
795,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,48,Up,0.969270628558657,0.995790115490268
796,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,24,Up,0.971327009586077,0.995790115490268
797,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,12,Down,0.972757430475507,0.995790115490268
798,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Down,0.97460263473928,0.995790115490268
799,WP_ACUTE_MYELOID_LEUKEMIA,55,Down,0.974910278493675,0.995790115490268
800,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Up,0.9754504758969,0.995790115490268
801,WP_16P112_PROXIMAL_DELETION_SYNDROME,62,Up,0.97581317259692,0.995790115490268
802,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,29,Down,0.976460152519844,0.995790115490268
803,WP_ANGIOGENESIS,13,Down,0.976891157060945,0.995790115490268
804,WP_CHOLESTASIS,9,Down,0.977241240345825,0.995790115490268
805,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,46,Down,0.977853728549846,0.995790115490268
806,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,27,Up,0.979068761314858,0.995790115490268
807,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,22,Up,0.980174520097841,0.995790115490268
808,WP_PURINE_METABOLISM,10,Down,0.981091971386389,0.995790115490268
809,WP_APOPTOSIS,71,Up,0.982161530461053,0.995790115490268
810,WP_TROP2_REGULATORY_SIGNALING,42,Down,0.982956225844858,0.995790115490268
811,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,9,Down,0.985510007679085,0.995790115490268
812,WP_ESTROGEN_SIGNALING,21,Down,0.986725619672974,0.995790115490268
813,WP_NONSMALL_CELL_LUNG_CANCER,58,Down,0.987052500539813,0.995790115490268
814,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Down,0.988499147384805,0.995790115490268
815,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Up,0.988994644646546,0.995790115490268
816,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,46,Up,0.990262246907222,0.995790115490268
817,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,7,Up,0.990465294761794,0.995790115490268
818,WP_FOXP3_IN_COVID19,9,Up,0.991080609065606,0.995790115490268
819,WP_15Q11Q13_COPY_NUMBER_VARIATION,33,Down,0.992961540016461,0.995790115490268
820,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,19,Down,0.993367268493941,0.995790115490268
821,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,37,Up,0.996014947193722,0.997228120089208
822,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,12,Up,0.998067608774951,0.998067608774951
